<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="3-part\PMC7141694\results\search\disease\results.xml">
  <result pre="CI:1.6–4.0)] and neurological symptoms [OR = 4.4 (95% CI:1.9–10.2)], and" exact="thrombocytosis" post="[OR = 2.2 (95% CI:1.1–4.0)] were associated with CHIKV"/>
  <result pre="infection, while atypical lymphocytes [OR = 8.3 (95% CI:4.2–16.7)] and" exact="thrombocytopenia" post="[OR = 8.1 (95% CI:1.7–38.8)] were associated with DENV"/>
  <result pre="acute febrile illness in Sindh region of Pakistan. Arthralgia and" exact="encephalitis" post="at time of presentation among patients with dengue-like illness"/>
  <result pre="Togaviridae. Both viral infections share similar disease manifestations including fever," exact="rash" post="and other non-specific findings. CHIKV presents after an incubation"/>
  <result pre="as an abrupt onset of febrile illness with arthralgia and" exact="rash" post="that resolves spontaneously in 7–10 days. However, in some"/>
  <result pre="assess role of arboviruses namely: Chikungunya, West Nile and Japanese" exact="encephalitis" post="virus as cause of fever in NDFI cases in"/>
  <result pre="had to be ruled out, i.e. typhoid by blood culture," exact="malaria" post="parasite by blood film and CBC to assist clinicians"/>
  <result pre="less than 10 years and &amp;gt;60 years, presence of chronic" exact="liver disease," post="haematological malignancies or chronic illnesses requiring use of steroids"/>
  <result pre="by IgM ELISA and RT-PCR. Hence, co-infection with dengue and" exact="chikungunya" post="was not evaluated. Fig 1 The diagnostic algorithm for"/>
  <result pre="&amp;lt;0.001 (as compared to 20% of CHIKV patients). For DENV," exact="thrombocytopenia" post="(defined as platelet count &amp;lt;150,000/mm3). was a significant predictor"/>
  <result pre="CI:1.6–4.0)] and neurological symptoms [OR = 4.4 (95% CI:1.9–10.2)], and" exact="thrombocytosis" post="[OR = 2.2 (95% CI:1.1–4.0)] were associated with CHIKV"/>
  <result pre="infection, while atypical lymphocytes [OR = 8.3 (95% CI:4.2–16.7)] and" exact="thrombocytopenia" post="[OR = 8.1 (95% CI:1.7–38.8)] were associated with DENV"/>
  <result pre="up to a ten-fold increase of ALT/AST from baseline in" exact="hepatitis" post="associated with severe DENV cases [22]. These findings are"/>
  <result pre="cases [22]. These findings are significant for Pakistan as chronic" exact="hepatitis" post="B and C along with other gastrointestinal infections are"/>
  <result pre="DENV in the differential diagnosis of patients presenting with fever," exact="hepatitis" post="and acute gastrointestinal symptoms. Pronounced musculoskeletal symptoms including polyarthralgia"/>
  <result pre="may have resulted in misdiagnosis of CHIKV infection as non-infectious" exact="arthritis" post="by clinicians at time of presentation and resultant use"/>
  <result pre="patients. No significant difference was seen in the frequency of" exact="rash" post="in both groups. The presence of comparatively lower systolic"/>
  <result pre="leucocyte counts and atypical lymphocytes were observed for DENV. Significant" exact="thrombocytopenia" post="was also found in DENV patients. This corroborates the"/>
  <result pre="Lancet Infectious diseases. 2007;7(5):319–27. Epub 2007/04/24. 10.1016/S1473-3099(07)70107-X17448935 4RaviV. Re-emergence of" exact="chikungunya" post="virus in India. Indian journal of medical microbiology. 2006;24(2):83–4."/>
  <result pre="2012/03/01. 10.1371/journal.pone.003002522363413 6RaufM, Fatima TuzZ, ManzoorS, MehmoodA, BhattiS. Outbreak of" exact="chikungunya" post="in Pakistan. The Lancet Infectious diseases. 2017;17(3):258. Epub 2017/03/01."/>
  <result pre="2017;17(3):258. Epub 2017/03/01. 7AamirUB, BadarN, SalmanM, AhmedM, AlamMM. Outbreaks of" exact="chikungunya" post="in Pakistan. The Lancet Infectious diseases. 2017;17(5):483 Epub 2017/04/28."/>
  <result pre="10.1016/S1473-3099(17)30191-328447956 8BarrKL, KhanE, FarooqiJQ, ImtiazK, PrakosoD, MalikF, et al.Evidence of" exact="chikungunya" post="virus disease in Pakistan since 2015 with patients demonstrating"/>
  <result pre="2017/09/20. 10.7759/cureus.143028924518 14ChaharHS, BharajP, DarL, GuleriaR, KabraSK, BroorS. Co-infections with" exact="chikungunya" post="virus and dengue virus in Delhi, India. Emerging infectious"/>
  <result pre="GerardinP, de BritoCAA, SoaresCN, FerreiraMLB, SolomonT. The neurological complications of" exact="chikungunya" post="virus: A systematic review. Reviews in medical virology. 2018;28(3):e1978"/>
  <result pre="KhalidR, AhmadJ, AshrafS, IqbalM, et al.Demographic and clinico-epidemiological features of" exact="dengue fever" post="in Faisalabad, Pakistan. PloSOne2014;9(3):e89868. 25Organization WH, Research SPf, Diseases"/>
  <result pre="11556587 28RiazMM, MumtazK, KhanMS, PatelJ, TariqM, HilalH, et al.Outbreak of" exact="dengue fever" post="in Karachi 2006: a clinical perspective. JPMA The Journal"/>
  <result pre="2014/09/26. 25253212 31TsetsarkinKA, VanlandinghamDL, McGeeCE, HiggsS. A single mutation in" exact="chikungunya" post="virus affects vector specificity and epidemic potential. PLoS pathogens."/>
  <result pre="10.1371/journal.pone.008225924312651 34NeogiDK, BhattacharyaN, MukherjeeKK, ChakrabortyMS, BanerjeeP, MitraK, et al.Serosurvey of" exact="chikungunya" post="antibody in Calcutta metropolis. The Journal of communicable diseases."/>
 </snippets>
</snippetsTree>
